These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4570447

  • 1. Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
    Walton KW, Craig GM, Prior P, Waterhouse JA, Skilton J.
    Br Heart J; 1973 Feb; 35(2):211-9. PubMed ID: 4570447
    [No Abstract] [Full Text] [Related]

  • 2. [Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography].
    Motomiya T.
    Nihon Naika Gakkai Zasshi; 1970 Feb 10; 59(2):117-25. PubMed ID: 4910199
    [No Abstract] [Full Text] [Related]

  • 3. Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans.
    Shimamoto T, Atsumi T, Yamashita S, Motomiya T, Isokane N, Ishioka T, Sakuma A.
    Am Heart J; 1970 Jan 10; 79(1):5-19. PubMed ID: 4903137
    [No Abstract] [Full Text] [Related]

  • 4. A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
    Zelikovsky A, Urca I, Shaklai M, de Vries A.
    Jpn Heart J; 1973 Jan 10; 14(1):12-21. PubMed ID: 4541560
    [No Abstract] [Full Text] [Related]

  • 5. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T, Atsumi T.
    Jpn Heart J; 1965 Sep 10; 6(5):407-15. PubMed ID: 5294603
    [No Abstract] [Full Text] [Related]

  • 6. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T, Atsumi T, Isokane N, Yamashita S, Sano T.
    Jpn Heart J; 1970 Sep 10; 11(5):433-49. PubMed ID: 4921577
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K, Oliva I, Linhart J, Prerovský I, Modr Z.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract] [Full Text] [Related]

  • 8. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
    Hunyi L.
    Ther Hung; 1976 Aug 27; 24(2):67-71. PubMed ID: 982342
    [No Abstract] [Full Text] [Related]

  • 9. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J, Lysakowska-Sernicka K, Gajewska A, Bilińska-Nigot B, Ostrowski K, Semenicki K.
    Neurol Neurochir Pol; 1978 Aug 27; 12(4):387-96. PubMed ID: 714218
    [Abstract] [Full Text] [Related]

  • 10. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
    Lucero Eseverri JA, Fajardo JD, Velles Aguirre L, Quijano E, Ciliberti E, Lucarelli R.
    Prensa Med Argent; 1970 Apr 24; 57(8):394-8. PubMed ID: 5517707
    [No Abstract] [Full Text] [Related]

  • 11. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI, Tolstova LG.
    Khirurgiia (Mosk); 1979 Sep 24; (9):76-80. PubMed ID: 502312
    [No Abstract] [Full Text] [Related]

  • 12. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
    Roztocil K, Oliva J, Linhart J, Prerovský I, Modr Z.
    Int J Clin Pharmacol Biopharm; 1977 Mar 24; 15(3):135-8. PubMed ID: 844932
    [Abstract] [Full Text] [Related]

  • 13. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
    Hunyi L.
    Ther Hung; 1978 Mar 24; 26(2):77-80. PubMed ID: 684660
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A, Borri P, Parravicini R.
    Minerva Cardioangiol; 1975 Nov 24; 23(11):701-10. PubMed ID: 1223674
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T, Motomiya T, Isokane N, Shimamoto T.
    Jpn Heart J; 1971 Jul 24; 12(4):335-46. PubMed ID: 5314713
    [No Abstract] [Full Text] [Related]

  • 16. [A double blind crossover trial in pyridinolcarbamate treatment of atherosclerosis obliterans].
    Yamashita S.
    Nihon Naika Gakkai Zasshi; 1969 Apr 10; 58(4):283-92. PubMed ID: 4896659
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans].
    Hess H, Goossens N, Keil-Kuri E, Zollner R, Meyer A.
    Vasa; 1972 Apr 10; 1(3):206-11. PubMed ID: 5076123
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of pyridinolcarbamate on the vasodilator action of bradykinin in the human forearm.
    Ludbrook J, Vincent AH, Walsh JA.
    Aust J Exp Biol Med Sci; 1973 Jun 10; 51(3):405-9. PubMed ID: 4766561
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.